Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9

BACKGROUND & AIMS: The cancer antigen 19-9 (CA19-9) is the current best biomarker for pancreatic cancer, but it is not increased in approximately 25% of pancreatic cancer patients at a cut-off value that provides a 25% false-positive rate. We hypothesized that antigens related to the CA19-9 anti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Mol Gastroenterol Hepatol
Main Authors: Tang, Huiyuan, Partyka, Katie, Hsueh, Peter, Sinha, Jessica Y., Kletter, Doron, Zeh, Herbert, Huang, Ying, Brand, Randall E., Haab, Brian B.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792034/
https://ncbi.nlm.nih.gov/pubmed/26998508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmgh.2015.12.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados